Transrectal Ultrasound Market Research Report with Forecast 2026 to 2035
Share With :
Transrectal Ultrasound Market Size is valued at USD 280.56 Mn in 2025 and is predicted to reach USD 526.45 Mn by the year 2035 at a 6.6% CAGR during the forecast period for 2026 to 2035.
Transrectal Ultrasound Market Size, Share & Trends Analysis Distribution by Product Type (Portable and Cart / Trolley-based), Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound, and Others), Application (Diagnostic [Benign Prostatic Hyperplasia, Prostate Cancer Diagnosis, Others] and Image-guided Biopsy), End-user (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others), and Segment Forecasts, 2026 to 2035
Transrectal Ultrasound Market Key Takeaways:
|
A diagnostic tool called transrectal ultrasound is used to identify male prostatic disorders, such as benign prostatic hyperplasia, prostatitis, and prostate cancer. It's a minimally invasive method that uses sound waves to create prostate pictures. A small probe is placed inside the rectum during a transrectal ultrasound technique, and sound waves are emitted that reflect off the surrounding tissues. The wave patterns, called echoes, that reflect off the organs are analyzed by a computer and transformed into an image that a physician can see on a television screen. One of the key factors driving the growth of the transrectal ultrasound market globally is the rising incidence of prostate cancer.
Furthermore, improvements in TRUS devices and increased government funding for the development of innovative treatments are anticipated to propel the transrectal ultrasound market expansion throughout the forecast period. For instance, the Prostate Cancer Research Program (PCRP) received funding from the Defense Appropriations Act in March 2023 to carry out high-impact prostate cancer research and create novel treatments. Additionally, methods for diagnosing prostate cancer that combine high-resolution ultrasound scanning, real-time elastography, MRI-US fusion biopsies, and systems with enhanced and effective imaging capabilities are being widely implemented. In order to diagnose prostate cancer, these systems are propelling the transition from traditional to sophisticated diagnostic methods.
Additionally, the adoption of transrectal ultrasound equipment is being accelerated by the vast and aging population base in developing nations like China and India as well as the growing healthcare infrastructure in these nations. Furthermore, the global transrectal ultrasound market is expanding due to the growing use of various tactics by major players in the industry, such as product launches and collaborations. The transrectal ultrasound market is expected to grow over the projected period due to an increase in research and development efforts by major players like GE Healthcare, Esaote SpA, and Exact Imaging to create novel and cutting-edge technologies. However, the expensive price of transrectal ultrasound equipment and transducers hinders market expansion.
• Siemens Healthineers AG
• GE Healthcare
• KOELIS
• FUJIFILM Corporation
• Telemed Medical Systems
• Exact Imaging
• Koninklijke Philips N.V.
• Mindray Medical International Limited
• Hitachi Medical Systems
• Strata Imaging
• Others
The global transrectal ultrasound market has been greatly impacted by the noticeable rise in awareness of prostate health in recent years. More men are seeking diagnostic treatments as a result of educational efforts and activities promoting prostate cancer screening. Since early discovery of prostate problems might result in improved treatment outcomes, this increased awareness is essential. As a result, more patients are choosing to have transrectal ultrasound exams performed, according to medical professionals. With projections indicating that the number of operations carried out annually may rise by 10% in the upcoming years, the market is anticipated to grow as more people realize the value of routine screenings. This pattern emphasizes how important prostate health is becoming to men's health.
The increasing demand for sophisticated alternative imaging modalities, especially multiparametric magnetic resonance imaging (mpMRI), for prostate cancer detection and assessment is a significant barrier to the transrectal ultrasound market. Compared to traditional TRUS, mpMRI provides better soft tissue contrast and increased precision in detecting clinically relevant prostate lesions, minimizing needless biopsies and boosting diagnostic confidence. Reliance on stand-alone TRUS procedures may decrease if medical professionals use MRI-guided or MRI-ultrasound fusion biopsy techniques more frequently. Additionally, clinicians are investigating transperineal and alternative image-guided techniques due to worries about TRUS-guided biopsy consequences include infection, bleeding, and patient discomfort.
The 2D Ultrasound category held the largest share in the Transrectal Ultrasound market in 2025 because of its regular clinical use in prostate assessment, accessibility, and price. Small hospitals, diagnostic facilities, and urology clinics generally like them since they are far less costly and simpler to run, especially in healthcare environments when money is tight. 2D ultrasound is frequently used by doctors to quantify prostate size, guide the positioning of the needle during biopsies, and track benign prostatic hyperplasia and other urological disorders. Additionally, growing awareness of prostate screening and developing countries' expanding healthcare infrastructure are pushing healthcare providers to start with dependable entry-level systems, which will support the 2D ultrasound category's growth and ongoing demand within the transrectal ultrasound market.
In 2025, the hospitals category dominated the Transrectal Ultrasound market due to the growing number of diagnostic and interventional procedures linked to the prostate that are carried out in hospital settings. For prostate cancer screening, biopsy, and treatment planning, hospitals are usually the main locations. TRUS is frequently utilized in these settings for therapy monitoring, prostate volume assessment, and needle guiding during biopsies. Increased patient traffic to urology departments due to the growing worldwide incidence of prostate cancer and the aging male population is increasing demand for TRUS equipment. Furthermore, hospitals have the financial means to purchase integrated imaging technologies, fusion biopsy systems, and sophisticated ultrasound platforms, all of which increase adoption.
The Transrectal Ultrasound market was dominated by North America region in 2025. The growing awareness of early diagnosis, the incidence of prostate-related disorders, and sophisticated healthcare infrastructure are the main drivers of the region's growth. In order to guarantee the availability of state-of-the-art technologies and gadgets, regulatory support from organizations such as the FDA further stimulates market expansion. Canada makes a substantial contribution to the North American market, which is led by the United States. Additionally, the continuous improvements in ultrasound technology, which improve patient outcomes and diagnostic accuracy, define the competitive landscape. The adoption of these technologies is facilitated by the existence of well-established healthcare systems, guaranteeing the transrectal ultrasound market’s continued expansion in this region.
| Report Attribute | Specifications |
| Market size value in 2025 | USD 280.56 Mn |
| Revenue forecast in 2035 | USD 526.45 Mn |
| Growth Rate CAGR | CAGR of 6.6% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product Type, Technology, Application, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Siemens Healthineers AG, GE Healthcare, KOELIS, FUJIFILM Corporation, Telemed Medical Systems, Exact Imaging, Koninklijke Philips N.V., Mindray Medical International Limited, Hitachi Medical Systems, Strata Imaging, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
• Portable
• Cart / Trolley-based
• 2D Ultrasound
• 3D Ultrasound
• 4D Ultrasound
• Others
• Diagnostic
o Benign Prostatic Hyperplasia
o Prostate Cancer Diagnosis
o Others
• Image-guided Biopsy
• Hospitals
• Specialty Clinics
• Diagnostic Imaging Centers
• Others
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.